David Krupadanam; Gazula Levi
Patent Applications and Registrations
Patent applications and USPTO patent grants for David Krupadanam; Gazula Levi.The latest application filed is for "c-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors".
- David Krupadanam; Gazula Levi - Hyderabad IN
| Patent | Date |
|---|---|
| C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors Grant 11,034,718 - Parthasaradhi Reddy , et al. June 15, 2 | 2021-06-15 |
| C-3 Novel Triterpenone With C-17 Reverse Amide Derivatives As Hiv Inhibitors App 20200087342 - PARTHASARADHI REDDY; Bandi ; et al. | 2020-03-19 |
| C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors Grant 10,533,035 - Parthasaradhi Reddy , et al. Ja | 2020-01-14 |
| C-3 Novel Triterpenone With C-28 Reverse Amide Derivatives As Hiv Inhibitors App 20180215780 - PARTHASARADHI REDDY; Bandi ; et al. | 2018-08-02 |
| Novel Betulinic Proline Imidazole Derivatives As Hiv Inhibitors App 20170129916 - PARTHASARADHI REDDY; Bandi ; et al. | 2017-05-11 |
| Betulinic acid proline derivatives as HIV inhibitors Grant 9,637,516 - Parthasaradhi Reddy , et al. May 2, 2 | 2017-05-02 |
| Novel Betulinic Acid Proline Derivatives As Hiv Inhibitors App 20150337004 - PARTHASARADHI REDDY; Bandi ; et al. | 2015-11-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 